SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-115253
Filing Date
2023-11-07
Accepted
2023-11-07 16:24:42
Documents
12
Period of Report
2023-11-06
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2330029d1_8k.htm   iXBRL 8-K 32192
  Complete submission text file 0001104659-23-115253.txt   205564

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pahc-20231106.xsd EX-101.SCH 3003
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE pahc-20231106_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pahc-20231106_pre.xml EX-101.PRE 22351
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2330029d1_8k_htm.xml XML 3380
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36410 | Film No.: 231384301
SIC: 2834 Pharmaceutical Preparations